Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03199885 |
|---|---|
| Brief Title: | Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer |
| First Submitted : | June 26, 2017 |
| First Submitted that Met QC Criteria : | June 26, 2017 |
| First Posted : | June 27, 2017 |
| Last Update Submitted that Met QC Criteria : | June 28, 2022 |
| Last Update Posted : | June 30, 2022 |